Picture of Intervacc AB logo

IVACC Intervacc AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Intervacc Says EMA Approves Extention Of Shelf Life For Strangvac To 33 Months

May 17 (Reuters) - Intervacc AB  IVACC.ST :
    * EUROPEAN MEDICINES AGENCY (EMA) APPROVES EXTENTION OF SHELF LIFE FOR STRANGVAC, A VACCINE
AGAINST EQUINE STRANGLES, TO 33 MONTHS

Source text for Eikon:  ID:nWkr3wkdbt 
Further company coverage:  IVACC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Intervacc AB

See all news